MRK.DE
MRK.DE
DE0006599905
MERCK KGAA I
Loading chart...

Company Profile

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Related stocks

SDZ.SW
SDZ.SW • Switzerland
SANDOZ GROUP N
69.72 CHF
36.35B USD 1Y +40.9%
HLN.L
HLN.L • United Kingdom
HALEON PLC ORD GBP0.01
349.2 GBp
40.64B USD 1Y +1%
GALD.SW
GALD.SW • Switzerland
GALDERMA GROUP N
164.95 CHF
46.34B USD 1Y +12.1%
SOBI.ST
SOBI.ST • Sweden
Swedish Orphan Biovitrum AB
428.4 SEK
14.92B USD 1Y +35.3%
IPN.PA
IPN.PA • France
IPSEN
142.7 EUR
13.18B USD 1Y +20.7%
TEVA
TEVA • Israel
Teva Pharmaceutical Industries
41.1 USD
47.93B USD 1Y +94.2%
TEVA.TA
TEVA.TA • Israel
TEVA PHARMA IND
12,000 ILA
45.74B USD 1Y +75.4%
DMP.DE
DMP.DE • Germany
Dermapharm Holding SE I
38.4 EUR
2.13B USD 1Y +15.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
28.1% p.a.
Max Drawdown (5Y)
-55.2%
Sharpe Ratio (5Y)
-0.31
Beta Factor
0.79
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (28.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -55.2% in the extended horizon.
ende